by The global Clinical Trials Support Services market size is expected to be worth around US$ 45.2 billion by 2030, according to a new report by Vision Research Reports.
Clinical Trials Support Services Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Service: Clinical trial site management, Patient recruitment management, Data management, Administrative staff, IRB, Others; By Sponsor: Pharmaceutical & biopharmaceutical companies, Medical device companies,Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38321
Growth Factors
The factors driving market growth include rising demand for drug development that necessitates and an increase in the number of CROs.
In the U.S., the biopharmaceutical sector contributes to around 90% of total spending on clinical trials for drugs and equipment. A clinical trial’s costs include data management, patient recruiting, site recruitment, and clinical procedure expenditures. Pharmaceutical firms have been gradually expanding their R&D investment in recent years. This was mostly due to a patent cliff in 2012, which resulted from several patent expirations.
The outbreak of COVID-19 is further expected to enhance demand for clinical trial support services throughout the forecast period. The majority of enterprises and businesses across the world are under threat from the rapidly developing risk caused by the spread of the COVID-19 disease. The current pandemic represents a serious threat to the wellbeing of the whole population. A key to effectively fighting COVID-19 lies in clinical research. The current situation across the globe and the need to think of treatment options have additionally prompted the most optimized plan to led clinical trials.
Key Players
- Charles River Laboratories
- IQVIA
- Pharmaceutical Product Development LLC
- WuXi AppTec
- Parexel International
- Icon PLC
- Laboratory Corp. of America Holdings
- Novotech
Market Segmentation
- Phase Outlook
- Phase I
- Phase II
- Phase III
- Phase IV
- Service Outlook
- Clinical trial site management
- Patient recruitment management
- Data management
- Administrative staff
- IRB
- Others
- Sponsor Outlook
- Pharmaceutical & biopharmaceutical companies
- Medical device companies
- Others
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38321
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Clinical Trials Support Services Market, By Phase
7.1. Clinical Trials Support Services Market, by Phase, 2021-2030
7.1.1. Phase I
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Phase II
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Phase III
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Phase IV
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Clinical Trials Support Services Market, By Service
8.1. Clinical Trials Support Services Market, by Service, 2021-2030
8.1.1. Clinical trial site management
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Patient recruitment management
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Data management
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Administrative staff
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. IRB
8.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Clinical Trials Support Services Market, By Sponsor
9.1. Clinical Trials Support Services Market, by Sponsor, 2021-2030
9.1.1. Pharmaceutical & biopharmaceutical companies
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Medical device companies
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Clinical Trials Support Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Phase (2016-2030)
10.1.2. Market Revenue and Forecast, by Service (2016-2030)
10.1.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Phase (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Service (2016-2030)
10.1.4.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Phase (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Service (2016-2030)
10.1.5.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Phase (2016-2030)
10.2.2. Market Revenue and Forecast, by Service (2016-2030)
10.2.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Phase (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Service (2016-2030)
10.2.4.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Phase (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Service (2016-2030)
10.2.5.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Phase (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Service (2016-2030)
10.2.6.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Phase (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Service (2016-2030)
10.2.7.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Phase (2016-2030)
10.3.2. Market Revenue and Forecast, by Service (2016-2030)
10.3.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Phase (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Service (2016-2030)
10.3.4.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Phase (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Service (2016-2030)
10.3.5.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Phase (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Service (2016-2030)
10.3.6.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Phase (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Service (2016-2030)
10.3.7.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Phase (2016-2030)
10.4.2. Market Revenue and Forecast, by Service (2016-2030)
10.4.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Phase (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Service (2016-2030)
10.4.4.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Phase (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Service (2016-2030)
10.4.5.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Phase (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Service (2016-2030)
10.4.6.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Phase (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Service (2016-2030)
10.4.7.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Phase (2016-2030)
10.5.2. Market Revenue and Forecast, by Service (2016-2030)
10.5.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Phase (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Service (2016-2030)
10.5.4.3. Market Revenue and Forecast, by Sponsor (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Phase (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Service (2016-2030)
10.5.5.3. Market Revenue and Forecast, by Sponsor (2016-2030)
Chapter 11. Company Profiles
11.1. Charles River Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. IQVIA
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Pharmaceutical Product Development LLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. WuXi AppTec
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Parexel International
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Icon PLC
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Laboratory Corp. of America Holdings
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Novotech
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38321
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
